18 June 2013
Keywords: biochem, pharma, receives, patent, lamivudine, announced, received
Article | 15 July 1996
- BioChem Pharma has announced that it has received a US protection
patent covering its once-daily, oral treatment lamivudine for chronic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 July 1996
© 2013 thepharmaletter.com